2013-02-26 12:58:31 -
ORION CORPORATION STOCK EXCHANGE RELEASE 26 February 2013 AT 13.55 EET
Orion Group's Annual Report for 2012 has been published. The report is available
in Finnish at ar2012.orion.fi and in English at
ar2012.orion.fi/en.
The official financial statement documents, which include the financial
statements, the report of the Board of Directors and the auditor's report are
available in Finnish at www.orion.fi/Orion/Yhtiokokoukset/Yhtiokokous-
2013/.
Orion's Corporate Governance Statement for year 2012, adopted by the Board of
Directors, is published as a separate report in Finnish at
www.orion.fi/en/Orion/Corporate-Governance/ and in English at
www.orion.fi/en/Orion/Corporate-Governance/.
Orion Corporation
Olli Huotari Terhi Ormio
SVP, Corporate Functions VP, Communications
Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo
www.orion.fi
Orion is a globally operating Finnish company developing
pharmaceuticals and
diagnostic tests - a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals, active pharmaceutical ingredients
and diagnostic tests. The company is continuously developing new drugs and
treatment methods. Pharmaceutical R&D focuses on central nervous system drugs,
oncology and critical care drugs, and Easyhaler® pulmonary drugs.
Orion's net sales in 2012 amounted to EUR 980 million and the company had about
3,500 employees. Orion's A and B shares are listed on NASDAQ OMX Helsinki.
Orion Corporate Governance Statement 2012:
hugin.info/3079/R/1681058/549405.pdf
Orion Group Annual Report 2012:
hugin.info/3079/R/1681058/549425.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Orion Oyj via Thomson Reuters ONE
[HUG#1681058]
